Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Birth control pills are effective for treating women with too much male hormone.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

Most patients improved with oral contraceptives, but some needed additional treatment.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

An 81-year-old woman's severe male hormone symptoms were caused by an ovarian tumor, which was treated with surgery.

Calculated testosterone values are reliable for assessing hyperandrogenemia in women, making direct measurement unnecessary.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Newborn acne may be linked to family history of high male hormone levels.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Statins can reduce androgen levels and improve symptoms in women with PCOS.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Postmenopausal hyperandrogenism involves excess male hormones causing symptoms like hair growth and acne, and requires ruling out tumors and other disorders.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.